Skip to content
CancerIndex

Publication

PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia.

Authors not recorded

Nat Genet2019PMID 30643249PMC6525306stubpubmedProvenance
Source
PubMed
Retrieved
Sep 8, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Run
ING-CIVIC-20260908-000001
Published

Abstract

Abstract (excerpt)

Only the opening of the abstract is shown; abstract text may carry publisher copyright.

Data not yet available

No abstract stored. Read on PubMed

Linked entities

Linked entities (7)

How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.

Validated 7

Curated evidence

Evidence citing this paper (5)

civicProvenance
Source
CIViC — Clinical Interpretation of Variants in Cancer
Dataset
CIViC evidence items
Version
civic-2026-09-08
Retrieved
Sep 8, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Evidence
expert curation
License
CC0 1.0
PMID
30643249
Run
ING-CIVIC-20260908-000001
Open at source
CuratedShowing 1–5 of 5 evidence items · levels, directions and significance as curated at the source; each row links to its CIViC record.
TherapyCancerTypeLevelDirection · significanceRating (1–5)StatusEvidenceSource
DUX4 Fusion + DUX4 Fusion1
(diagnostic)B Acute Lymphoblastic Leukemia with DUX4 RearrangementALIASDiagnosticBSupports Positive4submitted
EID11523

Integrated genomic analysis of was performed for 1,988 childhood and adult B-ALL cases. 106 cases (5.3%) showed DUX4 rearrangements, commonly with the IGH region. These cases were characterized by a u… (full text at CIViC)

PMID 30643249 · Gu et al., 2019 · Open in CIViC

civic
DUX4 Fusion1
(diagnostic)B Acute Lymphoblastic Leukemia with DUX4 RearrangementALIASDiagnosticBSupports Positive4accepted
EID12251

This study highlights the diagnostic significance of DUX4 rearrangements in identifying a distinct molecular subtype of B-lymphoblastic leukemia/lymphoma (B-ALL). Using transcriptome sequencing of 1,9… (full text at CIViC)

PMID 30643249 · Gu et al., 2019 · Open in CIViC

civic
PAX5 P80R2
(diagnostic)B Acute Lymphoblastic Leukemia with PAX5 P80R MutationALIASDiagnosticBSupports Positive3accepted
EID7291

Integrated genomic analysis was performed for 1,988 childhood and adult B-ALL cases. Forty four cases (2.2%) showed the P80R substitution in the DNA binding domain for the PAX5 transcription factor ge… (full text at CIViC)

PMID 30643249 · Gu et al., 2019 · Open in CIViC

civic
(oncogenic)B Acute Lymphoblastic Leukemia with PAX5 P80R MutationALIASOncogenicDSupports Oncogenicity4submitted
EID11522

To examine the effects of PAX5 P80R on B cell maturation, PAX5 WT, P80R, V26G, and P34Q were expressed in Pax5 depleted bone marrow cells. While PAX5 V26G and PAX5 P34Q could rescue B cell differentia… (full text at CIViC)

PMID 30643249 · Gu et al., 2019 · Open in CIViC

civic
PAX5 Fusion1
(diagnostic)B-lymphoblastic Leukemia With PAX5altUNRESOLVEDDiagnosticBSupports Positive5accepted
EID12867

This landmark study provided revised classification of B-lymphoblastic leukemia (B-ALL) based on integrated genomic findings from 1,988 childhood and adult B-ALLs. All cases were subjected to RNA-seq … (full text at CIViC)

PMID 30643249 · Gu et al., 2019 · Open in CIViC

civic